败血症生物标志物的前性分析:与临床结果的相关性
Vaishnavi Reddy1, Mahendra Wante1, Dakshayani S Nirhale1
1Department of General Surgery, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND.
Cureus
|November 7, 2024
概括
介质素-10 (IL-10),C反应蛋白 (CRP) 和公素 (PCT) 在预测败血症严重程度方面表现有前途. 升高的IL-10水平与更糟糕的结果相关,有助于手术性败血症患者的临床决策.
科学领域:
- 医学研究 医学研究
- 生物标志物的分析分析.
- 败血症诊断的诊断方法
背景情况:
- 败血症是一种严重的医疗状况,需要及时诊断和治疗.
- 进展到严重的败血症,败血性休克和死亡率是显著的风险.
- 早期识别败血症严重程度对于有效管理至关重要.
研究的目的:
- 评估介质素-10 (IL-10) 和常规标记在预测败血症严重性的诊断意义.
- 评估IL-10作为手术性败血症中新生物标志物的作用.
- 为了将生物标志物水平与败血症患者的临床结果相关联.
主要方法:
- 一项前性观察性研究,涉及100名患者,其快速序列器官衰竭评估 (qSOFA) 得分≥2.2.
- 在基线和各种时间点测量血清C反应蛋白 (CRP),前素 (PCT) 和介质蛋白-10 (IL-10) 水平.
- 使用接收器操作特征 (ROC) 曲线来确定生物标志物的诊断性能.
主要成果:
- 血清CRP水平在第7天与基线和早期时间相比显著增加.
- 血清PCT水平随着时间的推移显著下降.
- 入院时IL-10水平升高与多器官功能障碍综合征 (MODS) 的进展和死亡率有关.
- 在整个研究期间,IL-10水平显示出显著的上升趋势.
结论:
- IL-10,CRP和PCT是评估败血症严重程度的潜在预后标志物.
- 这些生物标志物的动态变化与临床结果相关.
- IL-10是识别患有手术性败血症恶化的患者和指导治疗决策的关键标志物.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
103
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
61
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61